The 2026 International Workshop on Alport Syndrome

Published on 05/09/2026

5-7 September 2026
Budapest, Hungary

ENYO Pharma will attend The 2026 International Workshop on Alport Syndrome, organized by Alport Syndrome Alliance.
It is an opportunity for the Alport community to connect, update and discuss the latest research.

ENYO Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients, with a poster titled “Vonafexor Stabilizes the Rapid eGFR Decline in Progressive Alport Syndrome: Results from the Phase 2 ALPESTRIA-1 Trial”.

https://www.alportsyndromealliance.org//

Read next in 'Events'

• ASN 2026 - American Society of Nephrology
• ASN - the American Society of Nephrology 2026
• PinUp Casino Kayıt Rehberi: Adım Adım Hesap Açma
• Boo Casino NZ Review: How It Works, Bonuses and Game Selection
• Boo Casino Handbook: A Practical Guide for New Zealand Players